News

Novo Nordisk reduces its starter dose prices through telehealth platforms to encourage weaning patients off compounded copycats.
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...
For Sharon Osbourne, her weight loss journey hasn't exactly been smooth sailing - especially when it comes to her use of ...
Dr. Mike Cirigliano joins Good Day Philadelphia to discuss the latest health topics, including the pros and cons of popular ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Speaking previously to E! News, Sharon claimed that, at her heaviest, she'd weighed over 230 pounds. She added at the time ...
Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...
Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...
A new study has found that a drug called semaglutide could help improve heart health in people who are overweight or obese, ...